We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Mar 2019
  • Code : CMI2524
  • Pages : 157
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for therapy of hypertension, in cardiac arrest, and in stroke management. Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis.  The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term.  Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.

Market Dynamics

Prevalence of high blood pressures, is increasing globally attributed to rising geriatric population, chronic disorders such as diabetes, and changing lifestyles which in turn is expected to increase the demand for telmisartan in global market. According to Blood Pressure UK, 2017 update, high blood pressure is the leading cause of heart disease and stroke, killing around 7.5 million people worldwide every year.  In 1975, 594 million people were suffering from high blood pressure which increased to 1.1 billion in 2015 and is thought to be due to population growth and an aging population. Thus, rise in geriatric population suffering from high blood pressure is expected to be major factor for growth of telmisartan market in the forecast period.

Furthermore, increasing approvals for Abbreviated new Drug Application (ANDA) for manufacturing of generic telmisartan tablets is propelling growth of telmisartan in the global market. For instance, in July 2014, Glenmark Generics Inc., USA—a subsidiary of Glenmark Generics Limited—received ANDA approval from the U.S. Food and Drug Administration (USFDA) for telmisartan tablets.

Key features of the study:

  • This report provides in-depth analysis of the telmisartan market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global telmisartan market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global telmisartan market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for telmisartan market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Telmisartan Market, By Strength:
    • 20mg
    • 40mg
    • 80mg
  • Global Telmisartan Market, By Indication:
    • Hypertension
    • Cardiac Arrest
    • Stroke
  • Global Telmisartan Market, By Composition:
    • Single
    • Combinational
  • Global Telmisartan Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Telmisartan Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • Global Telmisartan Market, By Strength:
        • 20mg
        • 40mg
        • 80mg
      • Global Telmisartan Market, By Indication:
        • Hypertension
        • Cardiac Arrest
        • Stroke
      • Global Telmisartan Market, By Composition:
        • Single
        • Combinational
      • Global Telmisartan Market, By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
  • Company Profiles
    • C.H. Boehringer Sohn AG & Ko. KG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Glenmark Generics Inc.
    • Torrent Pharmaceuticals Ltd.
    • Solco Healthcare U.S.
    • Aurobindo Pharma Limited
    • Mylan Inc.
    • Yichang Changjiang Pharmaceutical Co., Ltd
    • Wanbang Biopharmaceuticals.
    • Nippon Boehringer Ingelheim Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Strength
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Pipeline Analysis
    • Epidemiology
    • Historical Overview
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Telmisartan Market, By Strength, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • 20mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • 40mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • 80mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Telmisartan Market, By Indication, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cardiac Arrest
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Stroke
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Telmisartan Market, By Composition, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Single
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Combinational
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Telmisartan Market, By Distribution Channel, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  8. Global Telmisartan Market, By Regions, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Strength, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Composition, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • C.H. Boehringer Sohn AG & Ko. KG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Glenmark Generics Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Torrent Pharmaceuticals Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Solco Healthcare U.S.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Yichang Changjiang Pharmaceutical Co., Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Wanbang Biopharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nippon Boehringer Ingelheim Co., Ltd.
        • Company Overview.   
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 23 market data tables and 19 figures on "Telmisartan Market” - Global forecast to 2026”.

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

Esomar
Duns
Clutch
DMCA

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo